Fig. 1From: Design of TRUST, a non-interventional, multicenter, 3-year prospective study investigating an integrated patient management approach in patients with relapsing-remitting multiple sclerosis treated with natalizumabOverview of data documented in TRUST. (S)AE = (serious) adverse eventBack to article page